ACM
OM icon

AlphaCrest Capital Management’s Outset Medical OM Stock Holding History

AlphaCrest Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-409
Closed -$278K – 1333
2022
Q1 		$278K Buy
+409
New +$246K 0.02% 1128

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AlphaCrest Capital Management's OM Position: Q2 2022 in Review

AlphaCrest Capital Management sold out of Outset Medical (OM) in Q2 2022, closing a stake of 409 shares — an estimated $278K sold.

AlphaCrest Capital Management first reported a position in OM in Q1 2022 and held it in 1 quarter. The position peaked at $278K in Q1 2022. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • AlphaCrest Capital Management reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 409 Outset Medical shares in Q2 2022, an estimated $278K.
  • AlphaCrest Capital Management first reported a position in Outset Medical in Q1 2022 and held it in 1 quarter.
  • AlphaCrest Capital Management's Outset Medical position peaked at $278K in Q1 2022.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.